Trastuzumab Deruxtecan (T-DXd) in Patients With HER2-Positive Metastatic Breast Cancer (MBC): Updated Survival Results From a Phase 2 Trial (DESTINY-Breast01)
Trastuzumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trastuzumab Deruxtecan (T-DXd) in Patients With HER2-Positive Metastatic Breast Cancer (MBC): Updated Survival Results From a Phase 2 Trial (DESTINY-Breast01) ### Output: Trastuzumab Deruxtecan